Sweden’s Innovation Agency (Vinnova) - Grant for Innovative Startup

Reccan Diagnostics are awared a grant of 300.000 SEK for their work to develop a diagnostic and prognostic biomarker test for pancreatic cancer in serum and cancertissue.

 

Previous
Previous

Winner of the Lund University and Sparbanken Skåne award for future innovation

Next
Next

Recieves Lund University and Sparbanken Skåne honorary award for future innovation "Prognostic biomarker panel in pancreatic cancer".